CLINWON™-N

Clindamycin + Nicotinamide is a well-established topical combination widely used in the management of acne vulgaris due to its complementary and synergistic actions on multiple pathogenic factors of acne. Clindamycin is a lincosamide antibiotic that works by inhibiting bacterial protein synthesis, effectively reducing the population of Cutibacterium acnes on the skin and helping to control infection and inflammation within acne lesions. Nicotinamide, a biologically active form of vitamin B3, adds significant therapeutic value through its anti-inflammatory, sebum-regulating, and skin-barrier-strengthening properties. It helps calm redness, reduce swelling, and improve overall skin texture while also supporting skin healing and reducing post-acne marks. When used together, this combination not only targets acne-causing bacteria but also addresses excess oil production and inflammation, making it suitable for mild to moderate inflammatory acne. Dermapolis has formulated this powerful combination as CLINWON™-N, a carefully developed dermatological brand designed to deliver effective acne control with good skin tolerability. CLINWON™-N is created to ensure optimal penetration of active ingredients while minimizing irritation, making it suitable for regular use under dermatological guidance. With consistent application, CLINWON™-N helps reduce the number of active lesions, prevents the formation of new breakouts, and promotes clearer, healthier-looking skin. Backed by Dermapolis’ commitment to quality and dermatology-focused innovation, CLINWON™-N stands as a reliable option for individuals seeking an effective topical therapy for acne management.